project id: TCGA-MESO; case submitter id: TCGA-ZN-A9VQ; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.8; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.53; rna integrity number: 8.8; age at index: 61; days to birth: -22443; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1951; age at diagnosis: 22443; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 499.0; icd 10 code: C45.0; last known disease status: not reported; morphology: 9053/3; primary diagnosis: Mesothelioma, biphasic, malignant; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pleura, NOS; synchronous malignancy: No; tissue or organ of origin: Pleura, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 420; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-ZN-A9VQ-01A-11; percent lymphocyte infiltration: 60.0; percent monocyte infiltration: 10.0; percent necrosis: 5.0; percent neutrophil infiltration: 10.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;